BFEC
NVAX icon

Benjamin F. Edwards & Company’s Novavax NVAX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-268
Closed -$22K – 1741
2020
Q2 		$22K Sell
268
-1,100
-80% -$42.1K ﹤0.01% 1092
2020
Q1 		$19K Buy
1,368
+800
+141% +$6.77K ﹤0.01% 1097
2019
Q4 		$2K Hold
568
– – ﹤0.01% 1779
2019
Q3 		$3K Hold
568
– – ﹤0.01% 1694
2019
Q2 		$3K Sell
568
-1
-0.2% -$8 ﹤0.01% 1754
2019
Q1 		$6K Hold
569
– – ﹤0.01% 1450
2018
Q4 		$21K Buy
+569
New +$22.1K ﹤0.01% 1079

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Benjamin F. Edwards & Company's NVAX Position: Q3 2020 in Review

Benjamin F. Edwards & Company sold out of Novavax (NVAX) in Q3 2020, closing a stake of 268 shares — an estimated $22K sold.

Benjamin F. Edwards & Company first reported a position in NVAX in Q4 2018 and held it in 7 quarters. The position peaked at $22K in Q2 2020. 311 funds tracked by Wall St. Rank hold NVAX as of Q3 2020.

  • Benjamin F. Edwards & Company reported no remaining Novavax position as of Q3 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 268 Novavax shares in Q3 2020, an estimated $22K.
  • Benjamin F. Edwards & Company first reported a position in Novavax in Q4 2018 and held it in 7 quarters.
  • Benjamin F. Edwards & Company's Novavax position peaked at $22K in Q2 2020.
  • 311 funds tracked by Wall St. Rank held Novavax as of Q3 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2020, filed 13 Nov 2020.